Researchers have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a ...

A federally funded research team led by Sheri Holmen, PhD, investigator at Huntsman Cancer Institute and professor in the ...

Rodabe Amaria, MD, discusses the current role of OBX-115 for the treatment of patients with checkpoint inhibitor-resistant metastatic melanoma.

Onctura has dosed the first subject in the open-label Phase II OCULE-01 trial of oral roginolisib in individuals with rare eye cancer, metastatic uveal melanoma (UM). The randomised, parallel-arm ...

During a live event, James W. Smithy, MD, MHS, and other oncologists discussed how their experience with immune-related ...

A world where a robot quickly scans your body for skin cancer or your forehead lines stay frozen with just a treatment or two ...

Professor Richard Scolyer tells ABC Radio Sydney that a clinical trial is the next step for his melanoma research, but will ...

Mellencamp’s cancer journey began in March 2022 when she took to Instagram to reveal that she’d had a suspicious mole removed ...

Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with ...

After being diagnosed with advanced stage melanoma, Tash Sutton is on a mission to help others avoid the same fate.

Sep. 9, 2024 — The risk of skin cancer for adults under the age of 50 is now decreasing for the first time in ... Age-Related Changes in Male Fibroblasts Increase Treatment-Resistant Melanoma ...

As ROS levels surged, SFK activity spiked, helping melanoma cells withstand treatment. However, this adaptation was reversible – when treatment was removed, cells returned to their original state.